Area of research
Materials Chemistry · Cancer Research
Research interest
Research interests include Crystallization and Solubility Studies, MicroRNA in disease regulation, X-ray Diffraction in Crystallography, and Metal-Organic Frameworks: Synthesis and Applications.
Multiple large language models versus experienced physicians in diagnosing challenging cases with gastrointestinal symptoms
PLIN2 Promotes Lipid Accumulation in Ascites‐Associated Macrophages and Ovarian Cancer Progression by HIF1α/SPP1 Signaling
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial
Novel strategy to prepare pure Cu<sub>4</sub>TiSe<sub>4</sub> and its high-pressure Raman and thermoelectric performance investigation
A new thermoelectric compound Mg3Ag4Bi4: Preparation, crystal structure, DFT calculation and thermoelectric performance
Carbon Dots-Based Nanozyme for Drug-Resistant Lung Cancer Therapy by Encapsulated Doxorubicin/siRNA Cocktail
FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis
The role of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma
SSR2 overexpression associates with tumorigenesis and metastasis of Hepatocellular Carcinoma through modulating EMT
ZnAs@SiO<sub>2</sub> nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling
The Error-Prone DNA Polymerase κ Promotes Temozolomide Resistance in Glioblastoma through Rad17-Dependent Activation of ATR-Chk1 Signaling
MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1
miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells
<scp>M</scp>i<scp>R</scp>‐21 Modulates h<scp>TERT</scp> Through a <scp>STAT</scp>3‐Dependent Manner on Glioblastoma Cell Growth